Patent Assignment
Reel/Frame 039945/0001
Corrective Assignment to Correct the Receiving Party Data Previously Recorded at Reel: 039324 Frame: 0016. Assignor(S) Hereby Confirms the Assignment.
Recorded: 2016-09-08
Pages: 24
Assignor
BRISTOL-MYERS SQUIBB COMPANY
Executed: 2016-02-22
Assignee
VIIV HEALTHCARE UK (NO. 4) LIMITED
980 GREAT WEST ROAD, BRENTFORD, MIDDLESEX, TW89GS, UNITED KINGDOM
Covered Properties
(22)
Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
Application:
10/038,306 →
Publication:
US 2003/0069266
Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
Application:
10/214,982 →
Publication:
US 2003/0207910
Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
Application:
10/630,278 →
Publication:
US 2004/0110785
Composition and Antiviral Activity of Substituted Azaindoleoxoacetic Piperazine Derivatives
Composition and Antiviral Activity of Substituted Azaindoleoxoacetic Piperazine Derivatives
Pharmaceutical Formulations of Substituted Azaindoleoxoacetic Piperazine Derivatives
Pharmaceutical Formulations of Substituted Azaindoleoxoacetic Piperazine Derivatives with Protease Inhibitors
Application:
12/622,859 →
Publication:
US 2010/0093752
Pharmaceutical Formulations of Substituted Azaindoleoxoacetic Piperazine Derivatives with Protease Inhibitors
Application:
13/007,194 →
Publication:
US 2011/0118279
Pharmaceutical Formulations of Substituted Azaindoleoxoacetic Piperazine Derivatives with Protease Inhibitors
Application:
13/161,205 →
Publication:
US 2011/0245268
Pharmaceutical Formulations of Substituted Azaindoleoxoacetic Piperazine Derivatives with Protease Inhibitors
Application:
13/324,371 →
Publication:
US 2012/0095017
Pharmaceutical Formulations of Substituted Azaindoleoxoacetic Piperazine Derivatives with Protease Inhibitors
Application:
13/473,683 →
Publication:
US 2012/0238583
Pharmaceutical Formulations of Substituted Azaindoleoxoacetic Piperazine Derivatives with Protease Inhibitors
Application:
13/624,222 →
Publication:
US 2013/0030005
Pharmaceutical Formulations of Substituted Azaindoleoxoacetic Piperazine Derivatives with Protease Inhibitors
Application:
13/858,624 →
Publication:
US 2013/0289046
Pharmaceutical Formulations of Substituted Azaindoleoxoacetic Piperazine Derivatives with Protease Inhibitors
Application:
14/156,718 →
Publication:
US 2014/0135342
Pharmaceutical Formulations of Substituted Azaindoleoxoacetic Piperazine Derivatives with Protease Inhibitors
Application:
14/493,515 →
Publication:
US 2015/0087652
Substituted Azaindoleoxoacetic Piperazine Derivatives
Application:
14/725,298 →
Publication:
US 2015/0259342
Prodrugs of Substituted Azaindoleoxoacetic Piperazine Derivatives
Application:
14/725,318 →
Publication:
US 2015/0329543
Substituted Azaindoleoxoacetic Piperazine Derivatives
Application:
14/878,270 →
Publication:
US 2016/0075703
Prodrugs of Substituted Azaindoleoxoacetic Piperazine Derivatives
Application:
15/015,712 →
Publication:
US 2016/0152615
Substituted Azaindoleoxoacetic Piperazine Derivatives with Protease Inhibitors
Application:
15/071,329 →
Publication:
US 2016/0207918
Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
Application:
60/266,183 →
Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives
Application:
60/314,406 →
Related Assignments
(1)
Other recorded transfers of the patents in this record — the chain of ownership.